Composition and Function of Blood – Lecture Review

Composition of Whole Blood
  • Plasma: The liquid component that carries cells, nutrients, hormones, and waste products.

  • Red Blood Cells (Erythrocytes): Responsible for transporting oxygen from the lungs to the body and carbon dioxide from the body back to the lungs.

  • White Blood Cells (Leukocytes): Part of the immune system that helps fight infections and diseases.

  • Platelets (Thrombocytes): Essential for blood clotting and wound healing.

  • Whole blood: Composed of Plasma and Formed elements.

    sample of blood: 55% plasma and 45% formed elements

    • Plasma: (46\text{--}63\%)

    • Water: (92\%) of plasma content.

    • Plasma proteins: (7\%) of plasma content.

    • Other solutes: (1\%) of plasma content.

    • Functions: Transports organic/inorganic molecules, formed elements, and heat; regulates osmotic pressure, clotting, and immunity (via antibodies).

    • Formed elements: (37\text{--}54\%)

    • Platelets: <0.1\%

    • White blood cells (WBCs): <0.1\%

    • Red blood cells (RBCs): 99.9\% of the formed-element fraction.

Plasma Details
  • Constitutes (55\%) of a standard blood sample.

  • Water (92\%\text{ of plasma}): Acts as a solvent and heat buffer.

  • Protein categories & roles (7\%\text{ of plasma}):

    • Albumins: Regulate osmotic pressure.

    • Fibrinogen: A clotting precursor that converts to fibrin.

    • Globulins/antibodies: Crucial for immune defense.

Red Blood Cells (Erythrocytes)
  • Description:

    • Most abundant blood cell type.

    • Lack a nucleus, providing more internal room for hemoglobin (Hb).

    • Biconcave disc shape: Increases surface-area/volume ratio, aiding gas diffusion.

  • Major Function: Transport gases (O$2$, CO$2$) via hemoglobin (Hb).

Hemoglobin (Hb)

  • Description:

    • Approximately 280\text{ million} Hb molecules per RBC.

    • Each Hb molecule consists of 2 (\alpha)-chains and 2 (\beta)-chains (globin proteins).

    • Each chain contains one heme group with a central Fe$^{2+}$ ion.

    • Function: Fe$^{2+}$ reversibly binds O$2$ and CO$2$.

  • Normal Concentration (Ranges):

    • Men: 14\text{--}18\,\text{g\,dL}^{-1}

    • Women: 12\text{--}16\,\text{g\,dL}^{-1}

White Blood Cells (Leukocytes)
  • Description:

    • Contain nuclei (often lobed).

    • Lack Hb, thus no gas transport function.

  • Diapedesis: Ability to pass between capillary endothelial cells to enter tissues.

  • Function: Most are phagocytic, engulfing and destroying pathogens or debris.

  • Two Classes:

    • 1. Granular leukocytes (granulocytes):

    • Neutrophils (50\text{--}70\% of total WBCs):

      • Function: First responders at wounds; initiate infection control and phagocytize bacteria.

    • Eosinophils (2\text{--}4\% of total WBCs):

      • Function: Attack antibody-coated microbes/parasites; limit allergic responses.

    • Basophils (<1\% of total WBCs):

      • Function: Release histamine and other mediators at injury sites, leading to vasodilation and inflammation.

    • 2. Agranular leukocytes:

    • Monocytes (2\text{--}8\% of total WBCs):

      • Function: Arrive second at a wound after neutrophils; phagocytize dead neutrophils and pathogens, then become macrophages in tissues.

    • Lymphocytes (20\text{--}30\% of total WBCs) (smallest WBC):

      • Function: Provide specific (adaptive) immunity.

      • T-cells: Directly attack and destroy foreign/virus-infected cells.

      • B-cells: Become plasma cells that secrete antibodies targeting specific antigens.

Platelets (Thrombocytes)
  • Definition: Cell fragments derived from megakaryocytes.

  • Function: Essential for hemostasis (stopping bleeding) and clot formation.

Hematocrit (Packed Red Cell Volume)
  • Definition: Measures the volume percentage of formed elements in whole blood.

  • Indicator: Reflects O$_2$-carrying capacity.

    • Low value: Indicates anemia or reduced oxygen transport capacity.

  • Average Ranges:

    • Males: 40\text{--}54\%

    • Females: 37\text{--}47\%

Blood Coagulation
  • Process: Blood outside the body gels within 3\text{--}4 minutes.

  • Mechanism: A cascade of enzymes converts fibrinogen into insoluble fibrin.

    • Fibrin threads: Form a mesh that traps platelets and RBCs, sealing the wound with a clot.

  • Clinical Relevance: Deficiencies (e.g., hemophilia) or hyper-coagulation (thrombosis) are significant clinical issues.

ABO Blood Group System
  • Phenotypes: Four main types: A, B, AB, O.

  • Determination: Based on the presence of surface antigens (agglutinogens) on RBC membranes.

    • Antigen A, Antigen B: Can appear singly, together, or be absent.

  • Plasma Content: Plasma contains antibodies (agglutinins) against antigens missing from the individual's own RBCs.

    • Type A: Has Antigen A on RBCs; Anti-B antibodies in plasma.

    • Type B: Has Antigen B on RBCs; Anti-A antibodies in plasma.

    • Type AB: Has Antigens A & B on RBCs; No Anti-A/Anti-B antibodies in plasma (universal recipient).

    • Type O: Has No A/B antigens on RBCs; Both Anti-A & Anti-B antibodies in plasma (universal donor).

  • Blood Typing Test: Involves mixing an RBC sample with anti-A & anti-B sera to observe agglutination (clumping).

Rh (D) Blood Group
  • Categories: Rh + and Rh - (negative).

  • Determination: Based on the presence of the D (Rh) antigen on RBCs.

    • Rh +: D antigen is present; No anti-D antibodies are present initially.

    • Rh -: D antigen is absent; initial lack of anti-D antibodies.

    • Antibody Production: Exposure to Rh+ blood (e.g., via transfusion or pregnancy) sensitizes the immune system, leading to anti-D antibody production in Rh- individuals.

  • Usage: Used in conjunction with ABO to specify full blood type (e.g., A+, O-).

  • Clinical Note: Erythroblastosis fetalis (hemolytic disease of the newborn) can be prevented by administering anti-D immunoglobulin (RhoGAM) to Rh- mothers.

Practical & Clinical Connections
  • Transfusion Safety: Matching donor/recipient blood types (ABO & Rh) is crucial to prevent adverse transfusion reactions (agglutination, hemolysis).

  • Diagnostic Indicators:

    • Hematocrit & Hb measurements: Inform about conditions like anemia, polycythemia, and oxygen-delivery issues.

    • WBC differentials: Aid in diagnosing infections, allergies, and leukemia.

    • Coagulation studies: Guide anticoagulant therapy and evaluate bleeding disorders.

Cardiovascular System: Macro-Overview

  • Consists of three integrated components:

    • Pump: The heart (generates pressure to move blood)

    • Conducting hoses: Hierarchical network of blood vessels

    • Fluid connective tissue: Blood (focus of this lecture)

Blood – Definition, Functions & General Properties

  • Specialized connective tissue with cells suspended in a fluid matrix

  • Five cardinal functions:

    • Transport: dissolved gases, nutrients, hormones, metabolic wastes

    • Regulation: pH & ionic composition of interstitial fluid

    • Restriction: clot formation limits fluid loss at injury sites

    • Defense: WBCs & antibodies neutralize toxins/pathogens

    • Stabilization of body temperature (heat distribution & dissipation)

  • Key physical characteristics:

    • Temperature ≈ (38^\circ \text{C} = 100.4^\circ \text{F})

    • High viscosity (≈ 5× water)

    • Slightly alkaline: \text{pH } 7.35!\text{–}!7.45

    • Total volume: \text{Blood (L)} \approx 0.07 \times \text{body mass (kg)}

    • Example: 75\,\text{kg} \Rightarrow 5.25\,\text{L} (≈ 5.4\,\text{qt})

Fractionation of Whole Blood

  • Yields two major fractions

    1. Plasma (≈ 55\% of total volume)

    • >90\% water

    • Solutes: proteins, electrolytes, nutrients, gases, wastes

    • Similar to interstitial fluid due to capillary exchange of water/ions

    1. Formed Elements

    • Red blood cells (RBCs/erythrocytes)

    • White blood cells (WBCs/leukocytes)

    • Platelets (cell fragments)

Plasma Proteins (≈ 7\% of plasma by mass)

  • Synthesized >90 % in the liver (exception: antibodies by plasma cells, peptide hormones by endocrine glands)

  • Albumins (≈ 60\%)

    • Major contributors to plasma osmotic pressure

    • Transport lipids: fatty acids, thyroid hormones, steroid hormones

  • Globulins (≈ 35\%)

    • Immunoglobulins (antibodies)

    • Transport globulins: hormone-binding proteins, metalloproteins, apolipoproteins, steroid-binding proteins

  • Fibrinogen (≈ 4\%)

    • Soluble precursor → fibrin (insoluble) during coagulation; removal leaves serum

  • Other proteins (≈ 1\%): enzymes, proenzymes, hormones

Formed Elements & Hemopoiesis

  • Hemopoiesis: continuous production in red bone marrow (myeloid tissue)

    • Stem cell base: Hemocytoblasts / Hematopoietic Stem Cells (HSCs)

    • Myeloid stem cells → RBCs, platelets, all WBCs except lymphocytes

    • Lymphoid stem cells → lymphocytes

  • Rough relative abundance:

    • RBCs: \approx 99.9\% of formed elements

    • WBCs: <0.1\% (5 major classes)

    • Platelets: cell fragments involved in clotting

Platelets (Thrombocytes)

  • Small, membrane-bound cytoplasmic packets shed by megakaryocytes

  • Count: 150{,}000!–!500{,}000\,\text{(\mu L^{-1})}; ≈ 1/3 stored in spleen & other vascular organs

  • Lifespan: 9!–!12 days; cleared by splenic phagocytes

  • Functions:

    • Release clotting chemicals (e.g.ADP, thromboxane A2)

    • Form temporary platelet plug

    • Actin–myosin contraction reduces break size (clot retraction)

  • Hormonal regulation: Thrombopoietin (TPO), IL-6, Multi-CSF

  • Production process (thrombocytopoiesis): megakaryocyte cytoplasm continually sheds platelets

Red Blood Cells (Erythrocytes)

Numbers & Indices

  • RBC count per \mu\text{L} whole blood:

    • Adult male: (4.5!–!6.3) \times 10^6

    • Adult female: (4.2!–!5.5) \times 10^6

  • Hematocrit (PCV) – percent formed elements

    • Male: 46\% (±5)

    • Female: 42\% (±5)

  • Hemoglobin concentration

    • Male: 14!–!18\,\text{g dL}^{-1}

    • Female: 12!–!16\,\text{g dL}^{-1}

Structural Specializations

  • Biconcave disc: thin center, thicker rim →

    • High surface-area/volume ratio ⇒ rapid gas diffusion

    • Formation of rouleaux stacks ⇒ smooth flow in narrow vessels

    • Flexibility: 7.8\,\mu\text{m} diameter RBC can traverse 4\,\mu\text{m} capillary

  • Anucleate; lack mitochondria & ribosomes → anaerobic metabolism, fixed lifespan (≈ 120 days)

Hemoglobin Architecture & Function

  • Quaternary protein: 4 globin chains (2 α, 2 β) each bound to a heme with central \text{Fe}^{2+}

  • Reversible O$_2$ binding:

    • Oxyhemoglobin \text{HbO}_2 (bright red) Deoxyhemoglobin (dark red)

  • At systemic capillaries (low O$2$): releases O$2$, binds CO$_2$ → Carbaminohemoglobin

  • At lungs (high O2): releases CO2, loads O2

  • Payload: each RBC ≈ 2.8\times10^8 Hb molecules → > 10^9 O$_2$ molecules per cell

  • Fetal Hb has higher O$_2$ affinity → facilitates placental uptake

Erythropoiesis & Regulation

  • Sites: embryo → liver/spleen/thymus; adult → red bone marrow (myeloid tissue)

  • Stages: Myeloid stem cell → Proerythroblast → (various) Erythroblast stages → Reticulocyte (ejects nucleus; enters circulation) → Mature RBC

  • Erythropoietin (EPO): glycoprotein hormone from kidneys (+ liver) in response to hypoxia; accelerates cell division & Hb synthesis, speeds reticulocyte maturation

  • Nutritional requirements: amino acids, Fe, folic acid, vitamins B${12}$ & B$6$ (B$_{12}$ deficiency → pernicious anemia)

  • Performance manipulation: Blood doping (autologous RBC reinfusion or exogenous EPO) elevates hematocrit but risks viscosity-induced cardiac events

RBC Turnover & Hemoglobin Recycling

  • ~1\% of RBCs destroyed & replaced daily (≈ 3\times10^6\,\text{s}^{-1})

  • Aged RBCs phagocytosed by macrophages in spleen, liver, red marrow

  • Hemoglobin catabolism:

    • Globin → amino acids (recycled)

    • Heme iron → stored/transferred via transferrin; excess stored as ferritin/hemosiderin

    • Porphyrin ring → biliverdin (green) → bilirubin (yellow-orange) → liver bile → gut → urobilins/stercobilins (color feces & urine)

  • Pathologies:

    • Hemoglobinuria: free Hb in urine (brown/red) from excess intravascular hemolysis

    • Hematuria: whole RBCs in urine (renal vessel damage)

    • Jaundice: bilirubin accumulation from hepatic or duct obstruction

Blood Types & Immunohematology

Surface Antigens & Genetics

  • Erythrocyte membrane glycoproteins/lipids act as agglutinogens; inherited (codominant alleles)

  • ABO system: presence/absence of A & B antigens ⇒ four phenotypes

    • Type A: A antigen, plasma anti-B agglutinins

    • Type B: B antigen, plasma anti-A agglutinins

    • Type AB: A + B antigens, no anti-A/anti-B (universal recipient for cells)

    • Type O: no antigens, both anti-A & anti-B agglutinins (universal donor for cells)

  • Rh (D) antigen:

    • Rh⁺: antigen present

    • Rh⁻: antigen absent; develops anti-D only after sensitization (e.g.erythroblastosis fetalis)

  • >48 additional minor antigens → necessitate cross-matching

Transfusion Reactions (Cross-Reactions)

  • Occur when donor RBC agglutinogens interact with recipient plasma agglutinins → agglutination ± hemolysis → blocked vessels, Hb-mediated renal failure

  • Type O⁻: traditional universal donor, but compatibility testing (ABO + Rh + antibody screen) still mandatory

White Blood Cells (Leukocytes)

General Characteristics

  • Have nucleus & organelles, lack Hb

  • Distribution: majority reside in connective tissues & lymphoid organs; blood count: 5!\times!10^3!–!10\times!10^3\,\mu\text{L}^{-1}

  • Functional traits:

    • Emigration (diapedesis)

    • Amoeboid motility

    • Positive chemotaxis toward inflammatory signals

    • Phagocytosis (subset)

Major Classes

  1. Neutrophils (polymorphonuclear; 50!–!70\%)

    • Pale granules with lysosomal enzymes + bactericidal compounds

    • Rapid phagocytes; perform degranulation releasing defensins

    • Secrete prostaglandins & leukotrienes (inflammation control)

    • Short half-life (≈ 10 h); accumulation forms pus

  2. Eosinophils (2!–!4\%)

    • Attack multicellular parasites; phagocytose Ag-Ab complexes

    • Release NO & cytotoxic enzymes; modulate inflammation (counter mast cells)

    • Elevate in allergies & parasitic infections

  3. Basophils (<1\%)

    • Migrate to injury; granules release histamine (vasodilator) & heparin (anticoagulant)

  4. Monocytes (2!–!8\%)

    • Differentiate into macrophages after 24 h in blood

    • Large phagocytes; secrete chemotactic factors & fibroblast stimulants

  5. Lymphocytes (20!–!40\%)

    • Constant recirculation between blood & lymphatic tissues

    • Three functional sub-classes:

      • T cells: cell-mediated immunity; cytotoxic & regulatory types

      • B cells: humoral immunity; differentiate → plasma cells (antibody secretion)

      • NK cells: immune surveillance; destroy abnormal (virus-infected/cancer) cells

Quantitative Diagnostics

  • Differential count identifies shifts pointing to infection, allergies, leukemia, etc.

  • Disorders:

    • Leukopenia: low WBCs

    • Leukocytosis: high WBCs (normal mild infection response)

    • Leukemia: extreme leukocytosis; malignant clones

Leukopoiesis & Regulation

  • Hemocytoblast →

    • Myeloid stem cells → granulocytes & monocytes via progenitor cells

    • Lymphoid stem cells → lymphocytes (B, T, NK); T cell maturation in thymus

  • Colony-Stimulating Factors (CSFs) fine-tune populations:

    • Multi-CSF: broad (RBCs, platelets, granulocytes, monocytes)

    • GM-CSF, G-CSF, M-CSF act selectively

Hemostasis (Cessation of Bleeding)

1. Vascular Phase (Immediate – \le 30 min)

  • Vascular spasm: smooth-muscle contraction ↓ vessel diameter

  • Endothelial responses:

    • Expose basement membrane

    • Release ADP, tissue factor (Factor III), prostacyclin, endothelins (peptide vasoconstrictors)

    • Membranes become sticky → opposing surfaces seal micro-tears

2. Platelet Phase (Starts \approx 15 s)

  • Platelet adhesion to exposed collagen/basement membrane (via von Willebrand factor)

  • Platelet aggregation → platelet plug

  • Activated platelets secrete:

    • ADP (platelet activator)

    • Thromboxane A$_2$ & serotonin (vascular spasm enhancers)

    • Clotting factors, PDGF (promotes vessel repair), \text{Ca}^{2+}

  • Growth limiting mechanisms: prostacyclin, WBC-derived inhibitors, enzymatic ADP breakdown, negative feedback by serotonin, isolation by developing fibrin clot

3. Coagulation Phase (Starts \ge 30 s)

  • Cascade requiring 11 plasma proteins (proenzymes) + \text{Ca}^{2+} & vitamin K dependent synthesis

  • Extrinsic pathway: damaged tissue → Factor III + Ca^{2+} + Factor VII → activates Factor X

  • Intrinsic pathway: contact activation (collagen/PF-3) sequentially activates Factors XII → XI → IX → VIII → Factor X

  • Common pathway:

    • Factor X → prothrombin activator

    • Prothrombin → thrombin

    • Thrombin converts fibrinogen → fibrin strands (framework of clot)

    • Thrombin also positive-feedbacks extrinsic (↑ Factor III) & intrinsic (↑ PF-3) pathways ⇒ rapid amplification

Regulation / Limitation of Clot

  • Anticoagulants (endogenous):

    • Antithrombin III: inhibits thrombin & Factors IX, X

    • Heparin: from basophils/mast cells; accelerates antithrombin III

    • Thrombomodulin (endothelium) + thrombin → activates Protein C (inactivates Factors V & VIII, ↑ plasmin)

    • Prostacyclin: opposes platelet aggregation

  • Essential cofactors: \text{Ca}^{2+} (all pathways) & vitamin K (synthesis of Factors II, VII, IX, X)

  • Pathologies:

    • Thrombocytopenia (low platelets)

    • Hemophilia (Factor VIII/IX deficiency)

    • Thrombophilia (tendency to clot)

    • DVT (deep vein thrombosis)

Clot Retraction & Fibrinolysis

  • Retraction (mins–hrs): platelet actin–myosin pulls fibrin, draws wound edges together, ↓ residual bleeding

  • Fibrinolysis (clot removal): thrombin + t-PA activate plasminogen → plasmin; plasmin enzymatically digests fibrin network

Integration & Clinical Connections

  • Temperature homeostasis: blood rerouting to skin dissipates heat; shunting conserves heat

  • Anemia: ↓ O2 delivery triggers fatigue, pallor, tachycardia; etiologies include iron deficiency, pernicious, aplastic, hemolytic, hemorrhagic

  • Polycythemia/high hematocrit: ↑ viscosity → ↑ afterload & thrombosis risk

  • Leukemia treatments often exploit CSF manipulation & bone marrow transplantation

  • Anticoagulant therapy: heparin (acute), warfarin (vit K antagonist), direct Xa inhibitors; require monitoring of clotting times

  • Transfusion medicine: pre-transfusion type & screen, cross-match, Rh prophylaxis (RhoGAM) for Rh⁻ mothers

Here are quick bullet points on active, passive, and adaptive immunity:

  • Active Immunity:

    • Occurs when an individual's own immune system produces antibodies and memory cells in response to direct exposure to an antigen (e.g., natural infection or vaccination).

    • Provides long-lasting protection because the body remembers the pathogen.

  • Passive Immunity:

    • Occurs when an individual receives pre-formed antibodies from another source (e.g., mother to fetus via placenta, anti-venom).

    • Provides immediate but temporary protection because the body does not create its own memory cells or antibodies.

  • Adaptive (Specific) Immunity:

    • A highly specific type of immunity that develops throughout an individual's life in response to exposure to specific pathogens or antigens.

    • Involves specialized cells:

    • T-cells: Directly attack and destroy foreign or virus-infected cells.

    • B-cells: Become plasma cells that secrete antibodies targeting specific antigens.

    • Characterized by memory, allowing for a faster and stronger response upon subsequent exposure to the same pathogen.